{"DataElement":{"publicId":"3652971","version":"1","preferredName":"Hormone Therapy Raloxifene Received Current Medication Use Indicator","preferredDefinition":"Indicator of current Raloxifene usage","longName":"2405051v1.0:3624918v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2405051","version":"1","preferredName":"Hormone Therapy Raloxifene Received","preferredDefinition":"Information related to patient/participant having received Raloxifene which is a selective benzothiophene estrogen receptor modulator (SERM).  Raloxifene binds to and interacts with estrogen receptors (ER) as a mixed estrogen agonist/antagonist; it displays both an ER-alpha-selective partial agonist/antagonist effect and a pure ER-beta-selective antagonist effect.","longName":"HORMTX_RLXF_RCVD","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2433915","version":"1","preferredName":"Hormone Therapy","preferredDefinition":"Various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level. The treatment may include administration of hormones or hormone analogs to the patient, or decreasing the level of hormones in the body by using hormone antagonists, or hormone ablation therapy. The concept covers but not limited to: intermittent or permanent hormone suppression or ablation in treatment of hormone-dependent tumors, hormone replacement therapy of any kind, hormonal component of gender reassignment therapy, hormonal contraception, surgical and radiation castration.","longName":"C15445","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hormone Therapy","conceptCode":"C15445","definition":"Various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"06674CCB-CDA8-04A9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2743371","version":"1","preferredName":"Raloxifene Received","preferredDefinition":"A selective benzothiophene estrogen receptor modulator (SERM).  Raloxifene binds to and interacts with estrogen receptors (ER) as a mixed estrogen agonist/antagonist; it displays both an ER-alpha-selective partial agonist/antagonist effect and a pure ER-beta-selective antagonist effect.  This agent functions as an estrogen agonist in some tissues (bones, lipid metabolism) and as an estrogen antagonist in others (endometrium and breasts), with the potential for producing some of estrogen's beneficial effects without producing its adverse effects.  In postmenopausal women, raloxifene may reduce the risk of strokes, osteoporosis and breast cancer. (NCI04):Received; taken, gotten, or acquired.","longName":"C1518:C25639","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Raloxifene","conceptCode":"C1518","definition":"A selective benzothiophene estrogen receptor modulator (SERM).  Raloxifene binds to estrogen receptors (ER) as a mixed estrogen agonist/antagonist; it displays both an ER-alpha-selective partial agonist/antagonist effect and a pure ER-beta-selective antagonist effect.  This agent functions as an estrogen agonist in some tissues (bones, lipid metabolism) and as an estrogen antagonist in others (endometrium and breasts), with the potential for producing some of estrogen's beneficial effects without producing its adverse effects. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Receive","conceptCode":"C25639","definition":"To take, accept, or get something offered.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"4B2872C2-FB6D-0507-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-04-18","modifiedBy":"ONEDATA","dateModified":"2008-04-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0F2E-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-15","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-09-15","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3624918","version":"1","preferredName":"Current Medication Use Indicator","preferredDefinition":"Occurring in or belonging to the present time._A drug or medicine that treats or prevents or alleviates the symptoms of disease._put into service; make work or employ (something) for a particular purpose or for its inherent or natural purpose._An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"3624918v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"don't know","valueDescription":"Don't Know/Refused","ValueMeaning":{"publicId":"2654058","version":"1","preferredName":"Don't Know/Refused","longName":"2654058","preferredDefinition":"The answer is not known by the person answering.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Does Not Know","conceptCode":"C67142","definition":"The answer is not known by the person answering.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"32BD33B1-0E11-3D3A-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-06-12","endDate":null,"createdBy":"UMLLOADER_TOBACCO","dateCreated":"2007-06-12","modifiedBy":"TSESU","dateModified":"2023-03-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CDC30E79-24D9-E7B1-E040-BB89AD437B94","beginDate":"2012-11-05","endDate":null,"createdBy":"RODGERSC","dateCreated":"2012-11-05","modifiedBy":"ONEDATA","dateModified":"2012-11-05","deletedIndicator":"No"},{"value":"no","valueDescription":"No ","ValueMeaning":{"publicId":"2567170","version":"1","preferredName":"No","longName":"2567170","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D36F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-13","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-13","modifiedBy":"SOKKERL","dateModified":"2023-12-05","changeDescription":"Updated to add NCIt concept relationship. Updated VM Short Name to be the Public ID to be consistent with current convention for VM Short Name - DW 10-03-2022","administrativeNotes":"2022.12.29 Alt VM added per ticket request CADSR0001837. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CDC30E79-24E4-E7B1-E040-BB89AD437B94","beginDate":"2012-11-05","endDate":null,"createdBy":"RODGERSC","dateCreated":"2012-11-05","modifiedBy":"ONEDATA","dateModified":"2012-11-05","deletedIndicator":"No"},{"value":"yes","valueDescription":"Yes","ValueMeaning":{"publicId":"2560453","version":"1","preferredName":"Yes","longName":"2560453","preferredDefinition":"The affirmative response to a question or activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B932-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CLOHNES","dateModified":"2023-09-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"CDC30E79-24EF-E7B1-E040-BB89AD437B94","beginDate":"2012-11-05","endDate":null,"createdBy":"RODGERSC","dateCreated":"2012-11-05","modifiedBy":"ONEDATA","dateModified":"2012-11-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435024","version":"1","preferredName":"Drug or Chemical","preferredDefinition":"A category of organic or inorganic substances, elements, and isotopes used in research or for the prevention, diagnosis, and/or treatment of disease states. Includes biologically active substances that are either synthetically manufactured or endogenous substances extracted and processed to be reintroduced into an organism. Chemicals and drugs also include hazardous substances, and naturally occurring or synthetically produced substances required to maintain life.","longName":"C1908","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"07431EBC-FB04-25D9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3624917","version":"1","preferredName":"Current Medication Use Indicator","preferredDefinition":"Occurring in or belonging to the present time.:A drug or medicine that treats or prevents or alleviates the symptoms of disease.                           :put into service; make work or employ (something) for a particular purpose or for its inherent or natural purpose.:An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"C25471:C459:C0449865:C25180","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Current","conceptCode":"C25471","definition":"Occurring in or belonging to the present time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Medication","conceptCode":"C459","definition":"A drug product that contains one or more active and/or inactive ingredients; it is intended to treat, prevent or alleviate the symptoms of disease. This term does not refer to the individual ingredients that make up the product.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Use","conceptCode":"C0449865","definition":"put into service; make work or employ (something) for a particular purpose or for its inherent or natural purpose.","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CDC30E79-24B3-E7B1-E040-BB89AD437B94","latestVersionIndicator":"Yes","beginDate":"2012-11-05","endDate":null,"createdBy":"RODGERSC","dateCreated":"2012-11-05","modifiedBy":"ONEDATA","dateModified":"2012-11-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"CDC30E79-24C4-E7B1-E040-BB89AD437B94","latestVersionIndicator":"Yes","beginDate":"2012-11-05","endDate":null,"createdBy":"RODGERSC","dateCreated":"2012-11-05","modifiedBy":"PWEST","dateModified":"2015-11-02","changeDescription":"7/22/14 CDE released; VD released per Christine Rodgers. jc    10/5/12 created for UAMS cmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3029677","version":"1","longName":"UAMS Clinical Research","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812848","version":"1","longName":"UAMS New CDEs","context":"NCIP"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Are you currently taking ralo","type":"Preferred Question Text","description":"Are you currently taking raloxifene or Evista?","url":null,"context":"NCIP"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D36EB3C9-7CD2-E618-E040-BB89AD4350E1","latestVersionIndicator":"Yes","beginDate":"2013-01-16","endDate":null,"createdBy":"RODGERSC","dateCreated":"2013-01-16","modifiedBy":"RODGERSC","dateModified":"2015-02-25","changeDescription":"created for UAMS cmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}